Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun;104(2_suppl):368504211026119.
doi: 10.1177/00368504211026119.

Circulating furin, IL-6, and presepsin levels and disease severity in SARS-CoV-2-infected patients

Affiliations

Circulating furin, IL-6, and presepsin levels and disease severity in SARS-CoV-2-infected patients

Abdurrahim Kocyigit et al. Sci Prog. 2021 Jun.

Abstract

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in a vast number of infections and deaths that deeply affect the world. When the virus encounters the host cell, it binds to angiotensin-converting enzyme 2, then the S protein of the virus is broken down by the transmembrane protease serine 2 with the help of furin, allowing the virus to enter the cell. The elevated inflammatory cytokines suggest that a cytokine storm, also known as cytokine release syndrome, may play a major role in the pathology of COVID-19. Therefore, the aim of this study is to investigate the relationship between circulating furin levels, disease severity, and inflammation in patients with SARS-CoV-2. A total of 52 SARS-CoV-2 patients and 36 healthy control participants were included in this study. SARS- CoV-2 patients were scored by the disease activity score. Serum furin, presepsin, and interleukin-6 (IL-6) levels were assessed using an enzyme-linked immunosorbent assay. The mean furin, presepsin, and IL-6 levels were significantly higher in the peripheral blood of SARS-CoV-2 compared to the controls (p < 0.001). There were close positive relationship between serum furin and IL-6, furin and presepsin, and furin and disease severity (r = 0.793, p < 0001; r = 0.521, p < 0.001; and r = 0,533, p < 0.001, respectively) in patients with SARS-CoV-2. These results suggest that furin may contribute to the exacerbation of SARS-CoV-2 infection and increased inflammation, and could be used as a predictor of disease severity in COVID-19 patients.

Keywords: IL-6; SARS-CoV-2; disease severity; furin; inflammation; presepsin.

PubMed Disclaimer

Conflict of interest statement

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Correlations between circulating furin, IL-6, presepsin, and disease severity in patients with COVID-19.

References

    1. Huang C, Wang Y, Li X, et al.. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497–506. - PMC - PubMed
    1. Vankadari N.Overwhelming mutations or SNPs of SARS-CoV-2: a point of caution. Gene 2020; 752: 144792. - PMC - PubMed
    1. Zhang J, Zhou L, Yang Y, et al.. Therapeutic and triage strategies for 2019 novel coronavirus disease in fever clinics. Lancet Respir Med 2020; 8: e11–e12. - PMC - PubMed
    1. Mousavizadeh L, Ghasemi S.Genotype and phenotype of COVID-19: their roles in pathogenesis. J Microbiol Immunol Infect. 2021; 54(2): 159–163. - PMC - PubMed
    1. White JM, Whittaker GR.Fusion of enveloped viruses in endosomes. Traffic 2016; 17: 593–614. - PMC - PubMed